Free Trial

Evofem Biosciences (EVFM) SEC Filings & 10K Form

Evofem Biosciences logo
$0.0090 0.00 (-4.26%)
As of 04/2/2025 03:43 PM Eastern

Recent Evofem Biosciences SEC Filings

DateFilerForm TypeView
03/24/2025
7:30 AM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2025
5:10 AM
Evofem Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/23/2024
5:05 AM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:18 PM
Evofem Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
7:05 AM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
4:20 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
7:15 AM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
3:36 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2024
3:15 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
3:48 PM
Evofem Biosciences (Filer)
Form PRE 14A
08/30/2024
4:04 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2024
11:11 AM
Evofem Biosciences (Filer)
Form D
Notice of Exempt Offering of Securities 
08/14/2024
6:00 AM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
6:05 AM
Evofem Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/23/2024
3:30 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2024
3:35 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2024
3:30 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2024
7:15 AM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2024
3:46 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
5:45 AM
Evofem Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2024
5:50 AM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2024
4:28 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:EVFM) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners